Evidence map›Paper›PMID 36864206›Full record

ArticleNature metabolism2023

Lysosomal control of senescence and inflammation through cholesterol partitioning.

Kyeonghwan Roh, Jeonghwan Noh, Yeonju Kim, Yeji Jang, Jaejin Kim, Haebeen Choi, Yeonghyeon Lee, Moongi Ji, Donghyun Kang, Mi-Sung Kim and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 2 pooled it
22.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 2 syntheses or guidelines pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 3 countries.

Kyeonghwan Roh *School of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0002-6663-3578
Jeonghwan Noh *School of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0001-9891-6014
Yeonju KimSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0003-3241-0218
Yeji JangSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0001-9043-8943
Jaejin KimSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0003-0935-0552
Haebeen ChoiSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0002-5447-1065
Yeonghyeon LeeSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0002-3946-5660
Moongi JiCollege of Pharmacy, Sunchon National University, Suncheon, South Korea.
Donghyun KangSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0003-1966-1397
Mi-Sung KimSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0003-0320-735X
Man-Jeong PaikCollege of Pharmacy, Sunchon National University, Suncheon, South Korea.
Jongkyeong ChungSchool of Biological Sciences, Seoul National University, Seoul, South Korea.ORCID http://orcid.org/0000-0001-5894-7537
Jin-Hong KimSchool of Biological Sciences, Seoul National University, Seoul, South Korea. jinhkim@snu.ac.kr.ORCID http://orcid.org/0000-0002-6480-1929
Chanhee KangSchool of Biological Sciences, Seoul National University, Seoul, South Korea. chanhee.kang@snu.ac.kr.ORCID http://orcid.org/0000-0003-4350-5706
Seoul National University · KRSunchon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whereas cholesterol is vital for cell growth, proliferation, and remodeling, dysregulation of cholesterol metabolism is associated with multiple age-related pathologies. Here we show that senescent cells accumulate cholesterol in lysosomes to maintain the senescence-associated secretory phenotype (SASP). We find that induction of cellular senescence by diverse triggers enhances cellular cholesterol metabolism. Senescence is associated with the upregulation of the cholesterol exporter ABCA1, which is rerouted to the lysosome, where it moonlights as a cholesterol importer. Lysosomal cholesterol accumulation results in the formation of cholesterol-rich microdomains on the lysosomal limiting membrane enriched with the mammalian target of rapamycin complex 1 (mTORC1) scaffolding complex, thereby sustaining mTORC1 activity to support the SASP. We further show that pharmacological modulation of lysosomal cholesterol partitioning alters senescence-associated inflammation and in vivo senescence during osteoarthritis progression in male mice. Our study reveals a potential unifying theme for the role of cholesterol in the aging process through the regulation of senescence-associated inflammation.

Indexed as

InflammationLysosomesAnimalsCellular SenescenceMaleMammalsMechanistic Target of Rapamycin Complex 1MiceUp-RegulationMechanistic Target of Rapamycin Complex 1

Identifiers

PMID36864206
OpenAlexW4322766835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.